scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1399-5618.2002.01223.X |
P8608 | Fatcat ID | release_w2365tw3vng73fstknhtaqv4lq |
P698 | PubMed publication ID | 12519097 |
P50 | author | Sofia Frangou | Q7562874 |
Vanessa Raymont | Q66730592 | ||
P2093 | author name string | David Bettany | |
P2860 | cites work | Lithium, benzodiazepines, and sexual function in bipolar patients | Q28319919 |
Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants | Q28326442 | ||
The impact of substance abuse on the course of bipolar disorder | Q29306635 | ||
Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service | Q33808059 | ||
The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study | Q33850634 | ||
The accuracy of medication data in an outpatient electronic medical record | Q33873236 | ||
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? | Q33942947 | ||
Bipolar disorder therapeutics: maintenance treatment | Q34052830 | ||
Functional impairment and cognition in bipolar disorder | Q34057133 | ||
A needs index for mental health care | Q39462632 | ||
Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service | Q39540970 | ||
Can antidepressants cause mania and worsen the course of affective illness? | Q39677054 | ||
Lithium use and discontinuation in a health maintenance organization | Q41014056 | ||
Predictors of response to mood stabilizers | Q41033525 | ||
Chronic neuroleptic exposure in bipolar outpatients. | Q41498608 | ||
Identification of underprivileged areas | Q41908096 | ||
Adjunctive antipsychotic use in bipolar patients: an open 6-month prospective study following an acute episode | Q42616758 | ||
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
Illness characteristics and their association with prescription patterns for bipolar I disorder | Q43546337 | ||
Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
The enduring psychosocial consequences of mania and depression. | Q50608957 | ||
Rationale and design. PRiSM Psychosis Study I. | Q51987690 | ||
Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. | Q52228027 | ||
Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy. | Q52278359 | ||
Switch from depression to mania--a record study over decades between 1920 and 1982. | Q54635892 | ||
Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features | Q67567375 | ||
Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder | Q70906660 | ||
A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients | Q71496543 | ||
Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants | Q72078495 | ||
Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting | Q72536917 | ||
Lithium prophylaxis of bipolar illness. The value of combination treatment | Q72676297 | ||
Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association | Q72850842 | ||
Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study | Q73227813 | ||
Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study | Q73495126 | ||
Comparison of self-reported and physician-reported antidepressant medication use | Q74285219 | ||
P433 | issue | 6 | |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 378-385 | |
P577 | publication date | 2002-12-01 | |
P1433 | published in | Bipolar Disorders | Q15716681 |
P1476 | title | The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder | |
P478 | volume | 4 |
Q36422846 | ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder |
Q28478032 | Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature |
Q37143399 | Bipolar disorder: from genes to behavior pathways |
Q28251880 | Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder |
Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
Q57403974 | Fronto-temporal function may distinguish bipolar disorder from schizophrenia |
Q34272241 | Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India |
Q57403979 | Maudsley Bipolar Disorder Project: insights sobre o papel do córtex pré-frontal em pacientes com transtorno de humor bipolar tipo I |
Q39987572 | Nationwide and population-based prescription patterns in bipolar disorder |
Q36687844 | Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder |
Q34017887 | Omega-3 fatty acids in depression: a review of three studies |
Q37115466 | Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service |
Q30483204 | Point-counterpoint: the importance of "open access" to psychotropics for our patients |
Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
Q36199036 | Safety and tolerability of emerging pharmacological treatments for bipolar disorder |
Q28270756 | Structural brain correlates of response inhibition in Bipolar Disorder I |
Q48867377 | The Maudsley Bipolar Disorder Project |
Q33570874 | The metabolic basis of cognitive insight in psychosis: A positron emission tomography study |
Q22241428 | Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice |
Q47367652 | Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence? |
Q79905027 | [Epidemiology of medication prescriptions in bipolar disorder] |
Q57911681 | fMRI in Psychiatric Disorders |